Form 4 for COLL COLLEGIUM PHARMACEUTICAL, INC
Accepted 2025-02-12 00:00:00 ET · period of report 2025-02-10 · accession 0001062993-25-002179 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-02-12 | 2025-02-10 | COLL | Dreyer Scott | EVP, Chief Commercial Off | F - Tax | $30.52 | -29.6K | 169.4K | -15% | -$904.1K |
| M | 2025-02-12 | 2025-02-10 | COLL | Dreyer Scott | EVP, Chief Commercial Off | A - Grant | $0.00 | +71.4K | 177.3K | +67% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-10 | F | D | 21,670 | $30.52 | 147,706 | D | — | — | (F4) Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs. |
| 2 | Common | Common Stock | 2025-02-10 | F | D | 7,953 | $30.52 | 169,376 | D | — | — | (F3) Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs. |
| 3 | Common | Common Stock | 2025-02-10 | A | A | 45,016 | $0.00 | 150,918 | D | — | — | (F1) Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2026, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock. |
| 4 | Common | Common Stock | 2025-02-10 | A | A | 26,411 | $0.00 | 177,329 | D | — | — | (F2) Effective February 10, 2025, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 26,411 performance share units ("PSUs") granted in the Issuer's three prior fiscal years. |